ROARABLE
FREE $100K
Today Screener Big Ideas Track Record πŸ’° $100K Arena 🎲 Predictions πŸ›οΈ Insiders 8 Analysts
Stock Ratings / Technology / HNGE / options
QNT (53) AUR (37) JKHY (82) EPAM (83) ⌘ Pro Terminal β†’

Hinge Health Inc. (HNGE) Options Positioning, Max Pain & Unusual Sweeps

$115.48 +1.01% NYSE β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $115.47

Hinge Health Inc. (HNGE) carries a Roarable Rating of C+ (Hold) with 68/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C+ β€’ HOLD / WATCH Cap $9.22B
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on HNGE Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is HNGE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-03, Hinge Health Inc. (NYSE: HNGE) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 68/100 at a spot price of $115.48 (+1.01% 1D, market cap $9.22B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 19/20, SEC Balance-Sheet Forensics 16/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 10/20. Across 715 tracked Technology issuers, HNGE ranks #105 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does HNGE compare to QNT and AUR in the Technology sector?
β–Ό

Within the Technology sector (EDP Services), HNGE carries a Roarable C+ (68/100 RQD), trailing P/E of N/A, gross margin of 79.6%, and ROIC of -35.0%. By comparison, QNT (Quantinuum Inc.) holds a D+ grade (53/100 RQD, P/E 21.7x, ROIC 58.3%, cap $8.93B) and AUR (Aurora Innovation Inc.) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $8.81B). Among the 5-stock peer group, EPAM leads on earnings multiple (18.4x) while QNT leads on capital efficiency (58.3% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for HNGE?
β–Ό

Per HNGE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001673743), Hinge Health Inc. generated $587.9M in revenue (+50.6% YoY), -$528.3M in net income, and $170.7M in free cash flow against $744.8M in total assets and $164.8M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $115.47 (-0.01%)🧬 Disciplined Float (+0.52% YoY Shares)βš™οΈ Cash Engine: 13/20 (C) β€’ 29% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record: Scores of 68/100 (C+) historically posted market-perform odds over rolling 90-day windows (+1.8% avg 90D alpha vs SPY β€’ 56.9% hit rate β€” wait for RQD β‰₯ 70 breakout).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERHOLD / WATCH β€’ C+
025507510068
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B- Β· Rk C
Cash (13)Whales (19)SEC (16)Macro (10)CEO (10)
Each axis scored 0–20
12M PRICE TARGET CONE+4.5% Base Target
$142 Bull$121 Base$94 Bear
πŸ“¬ FREE HNGE RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for HNGE)Realized 20D OHLCV Swing Band: Β±8.2%
Deterministic 5-Pillar Attribution (68/100 Composite)
πŸ” WHY HNGE SCORES 68/100 (C+) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: Whale & Options Positioning+19/20 pts (28% of score)

20D Institutional Volume Accumulation (Β±8.2% realized swing band)

β–² #2 Bullish Driver: SEC 10-K Forensic Risk+16/20 pts (24% of score)

Altman Z-Score 12.12 (FORTRESS SAFE (>3.0)) β€’ Piotroski F-Score 7/9

β–Ό #1 Drag / Risk Factor: Insider Conviction & Share Dilution10/20 pts (-10 pt drag)

Disciplined Float (+0.52% YoY Shares) & executive Form 4 sales trim 10 pts from alignment

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
60
Grade C$105.00+6.7% Next Q
Q2 (-2Q)
63
Grade C+$112.00+2.9% Next Q
Q3 (-1Q)
65
Grade C+$115.28+0.2% Next Q
Current
68
Grade C+$115.48+1.8% Hist 90D Ξ±
Trajectory: C (60) β†’ C+ (68)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

βš”οΈ Adversarial Opposing Case: Why the HNGE Bull Thesis Could Fail

Gideon Ashmere Forensic Desk β†’

Even with a 68/100 (C+) score, HNGE faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($99.77) or 200D SMA ($68.16) invalidates the momentum regime and cuts Target Base ($120.68) toward Bear Floor ($94.13).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $HNGEβ€’ $4.8M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œHNGE Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”
YES 68%NO 32%Trade / Inspect Odds β†’
CALL VS. PUT WHALE SHARE
β€” (No Active Options Snapshot)
Put/Call Ratio: β€” (No Active Options Snapshot)
MAX-PAIN EXPIRATION MAGNET
β€” (No Active Options Snapshot)
No active options chain max-pain snapshot on file
HISTORICAL 20D VOLATILITY SWING
Β±8.2%
Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (HNGE)

β€” (No Active Options Snapshot) β€” No unusual CBOE strike concentration anomalies recorded in the current database snapshot for HNGE.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

πŸ† Enter Free $100K Paper Arena β†’
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating HNGE & AI Leaders Without Chasing Tops

  • βœ“Institutional whale strikes & implied earnings move audit on HNGE
  • βœ“How disciplined traders manage risk using pre-published trigger & invalidation levels
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) β†’$100K Arena
HNGE // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +136.20%⚑ TESTING RESISTANCE
2026-11-03O $116.9H $116.9L $114.3C $115.5VOL 2.89M
RES: $119.5SMA50: $99.77SMA200: $68.16
$122.8$101.0$79.18$57.36$35.54RES $119.5$115.52026-05-042026-06-182026-08-052026-09-212026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HNGE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

πŸ¦‹ HNGE Butterfly Map β†’ + Track HNGE β†’
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
22.3%/yr Implied 5Y Growth

vs. +50.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on HNGE today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for HNGE. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for HNGE today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HNGE)

Technology Rank #105 of 715 βš”οΈ QNT vs HNGE Full Matrix β†’

1. Head-to-Head Technology Peer Comparison (HNGE vs. QNT, AUR, JKHY, EPAM)

Industry: EDP Services (163 Tracked Issuers)

Across 715 tracked Technology securities in the Roarable RQD universe, Hinge Health Inc. (HNGE) ranks #105 by composite RQD confidence (68/100, grade C+) and #153 by equity capitalization ($9.22B). Within this direct 5-issuer industry benchmark cohort, EPAM leads on earnings valuation at 18.4x trailing P/E, while QNT leads on capital efficiency and profitability with 58.3% ROIC and β€” gross margin. EPAM currently holds the highest overall quantitative score in the immediate peer group at 83/100 (A-) compared with HNGE at 68/100 (C+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
HNGE ACTIVE
Hinge Health Inc.
C+ 68/100 β€” 79.6% -35.0% +1.01% $9.22B Benchmark Subject
QNT
Quantinuum Inc.
D+ 53/100 21.7x β€” 58.3% -7.89% $8.93B /qnt-vs-hnge β†’
AUR
Aurora Innovation Inc.
D- 37/100 β€” -30.0% -35.0% -2.98% $8.81B /aur-vs-hnge β†’
JKHY
Jack Henry & Associates Inc.
A- 82/100 24.6x 42.7% 20.5% +1.29% $11.31B /jkhy-vs-hnge β†’
EPAM
EPAM Systems Inc.
A- 83/100 18.4x 28.8% 17.1% +2.34% $7.25B /epam-vs-hnge β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0001673743 β†—

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Hinge Health Inc. (HNGE) reported GAAP revenue of $587.9M (+50.6% vs. FY2024 revenue of $390.4M , and +100.8% cumulative change since FY2023) , GAAP net income of -$528.3M, operating cash flow of $171.4M, and free cash flow of $170.7M (+256.0% YoY). On the balance sheet, HNGE closed FY2025 with $744.8M in total assets against $164.8M in total debt (Altman Z-Score: 12.12, Piotroski F-Score: 7/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $587.9M -$528.3M $171.4M $170.7M $744.8M $164.8M
FY2024 (FY) 2024-12-31 $390.4M -$11.9M $49.0M $48.0M $673.3M $115.5M
FY2023 (FY) 2023-12-31 $292.7M -$108.1M -$63.9M -$77.1M $5.19B $1.21B

3. HNGE Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HNGE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Hinge Health Inc. (NYSE: HNGE) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 68/100 at a spot price of $115.48 (+1.01% 1D, market cap $9.22B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 19/20, SEC Balance-Sheet Forensics 16/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 10/20. Across 715 tracked Technology issuers, HNGE ranks #105 in composite RQD confidence.

How does HNGE compare to QNT and AUR in the Technology sector?

Within the Technology sector (EDP Services), HNGE carries a Roarable C+ (68/100 RQD), trailing P/E of N/A, gross margin of 79.6%, and ROIC of -35.0%. By comparison, QNT (Quantinuum Inc.) holds a D+ grade (53/100 RQD, P/E 21.7x, ROIC 58.3%, cap $8.93B) and AUR (Aurora Innovation Inc.) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $8.81B). Among the 5-stock peer group, EPAM leads on earnings multiple (18.4x) while QNT leads on capital efficiency (58.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for HNGE?

Per HNGE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001673743), Hinge Health Inc. generated $587.9M in revenue (+50.6% YoY), -$528.3M in net income, and $170.7M in free cash flow against $744.8M in total assets and $164.8M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is HNGE trading relative to its 50-day, 200-day, and 52-week technical levels?

HNGE last traded at $115.48 (+1.01% on volume of 2,314,382 shares), positioning the stock +15.75% above its 50-day simple moving average ($99.77) and +69.42% above its 200-day simple moving average ($68.16). Across its 52-week range of $30.08 to $117.55, HNGE sits at the 97.6% percentile with a 14-day RSI of 63.7 (BULLISH MOMENTUM) and an implied next-earnings move of Β±8.2% ($106.01 to $124.95).

Direct Sub-Reports: HNGE RQD Cockpit HNGE 12M Forecast HNGE Earnings & Move HNGE Dividends & DRIP HNGE Insiders & 13F HNGE Whale Options HNGE Profit Sankey HNGE News & Why
ROARABLE RATING BRIEF β€’ RQD 68/100 (C+) βœ“ SEC XBRL & RQD VERIFIED

HNGE β€” Hinge Health Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Hinge Health Inc. (HNGE) earns a live Roarable RQD composite score of 68/100, corresponding to a C+ letter grade (Roarable Hold) at a spot price of $115.48 (+1.01% 1D, market capitalization $9.22B).

  • Fundamental Cash Engine (13/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 79.6%, operating margin of -60.0%, and free cash flow yield of 1.81%.
  • Whale 13F & Options Flow (19/20) + Insider Conviction (10/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (10/20) + Forensic Balance Sheet (16/20): Incorporates a 1.24x equity beta, Altman Z-Score of 12.12, Piotroski F-Score of 7/9, and Debt/Equity of 0.86x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Hinge Health Inc. Is a NYSE-listed issuer classified in the Technology sector and the EDP Services industry. Gross margin of 79.6% is reported in the market data section.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Hinge Health Inc. (HNGE) reported $587.9M in annual revenue (up from $390.4M in FY2024, +50.6% YoY) and -$528.3M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($292.7M revenue, -$108.1M net income) through FY2025, HNGE scaled operating cash flow to $171.4M and free cash flow to $170.7M, backed by $744.8M in total assets against $164.8M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • πŸ‚ Primary Bull Case (C+ β€’ RQD 68/100): Big institutional funds and options desks are actively positioning on the bullish side. Clean SEC annual filing review with no major hidden accounting time-bombs. With Fundamental Cash Engine at 13/20 and Institutional Whale Flow at 19/20, sustained execution supports upside toward the upper end of the $30.08 – $117.55 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -60.0% operating margins and a 1.24x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

The source data therefore does not identify upstream suppliers, downstream customers, or sector correlations. Second-order ripples cannot be mapped from the provided data. A prospective investor should note that the absence of linkage data is itself a gap, not evidence of independence.

  • Key Question #1: Can HNGE sustain or expand its -60.0% operating margin and -35.0% ROIC against EDP Services peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $587.9M and free cash flow of $170.7M, how will capital allocation balance growth reinvestment against $164.8M in total debt?
  • Key Question #3: How sensitive is HNGE's 29.0x forward P/E multiple to Technology capital spending cycles and macro interest-rate shifts (Beta 1.24x)?

HNGE Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Hinge Health Inc. (HNGE) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to HNGE Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

HNGE Bull vs. Bear Conversation Board β€” What's Your Call at $115.48?

πŸ‚ 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON HNGE 🐻 33% BEARISH CONVICTION
1. Pick Your Side on HNGE:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
BR BreakoutHunter RQD DEBATE OPENER β€’ Swing & Catalyst Trader πŸ‚ BULLISH 🎯 Target: $132.61 (+16.0%)
πŸ“Œ Pinned Debate

Institutional accumulation and options positioning score 19/20 in the Roarable RQD rating, the strongest pillar, alongside a 12.12 Altm

Picked up a starter position in HNGE in my $100K Virtual Cash book at $114.32. Institutional accumulation and options positioning score 19/20 in the Roarable RQD rating, the strongest pillar, alongside a 12.12 Altman Z-Score.. Trading inside a $30.08–$117.55 52-week range with 1.81% FCF yield gives solid downside support if EDP Services multiples expand this quarter.

CapAlloc_Nerd πŸ‚ BULL

@BreakoutHunter Agree on the RQD 68/100 quality, though with 1.24 beta I'm scaling in with half-size at $114.32 and keeping dry powder in case we test $106.32.

ME MeanReversion_88 RQD DEBATE OPENER β€’ Quantitative Statistical Arb 🐻 BEARISH 🎯 Target: $85.74 (-25.0%)
Spot @ $114.32

ROIC of -35%, operating margin of -60%, and a forward P/E of 29 leave the cash engine (13/20) and valuation exposed if earnings do not

Here is the bear case nobody on the bull side wants to address on HNGE: ROIC of -35%, operating margin of -60%, and a forward P/E of 29 leave the cash engine (13/20) and valuation exposed if earnings do not improve.. At 29.0x forward P/E, even a small guidance miss in EDP Services triggers a 12-15% air pocket.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%